JPS59206305A - ニモジピンの非経口投与組成物 - Google Patents

ニモジピンの非経口投与組成物

Info

Publication number
JPS59206305A
JPS59206305A JP59086280A JP8628084A JPS59206305A JP S59206305 A JPS59206305 A JP S59206305A JP 59086280 A JP59086280 A JP 59086280A JP 8628084 A JP8628084 A JP 8628084A JP S59206305 A JPS59206305 A JP S59206305A
Authority
JP
Japan
Prior art keywords
composition
weight
parenteral administration
nimodipine
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59086280A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0422888B2 (enExample
Inventor
デイ−タ−・ホツフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS59206305A publication Critical patent/JPS59206305A/ja
Publication of JPH0422888B2 publication Critical patent/JPH0422888B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
JP59086280A 1983-05-06 1984-05-01 ニモジピンの非経口投与組成物 Granted JPS59206305A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833316510 DE3316510A1 (de) 1983-05-06 1983-05-06 Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3316510.6 1983-05-08

Publications (2)

Publication Number Publication Date
JPS59206305A true JPS59206305A (ja) 1984-11-22
JPH0422888B2 JPH0422888B2 (enExample) 1992-04-20

Family

ID=6198265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59086280A Granted JPS59206305A (ja) 1983-05-06 1984-05-01 ニモジピンの非経口投与組成物

Country Status (19)

Country Link
US (1) US5114956A (enExample)
EP (1) EP0126315B1 (enExample)
JP (1) JPS59206305A (enExample)
KR (1) KR920000306B1 (enExample)
AT (1) ATE24835T1 (enExample)
AU (1) AU562293B2 (enExample)
BE (1) BE899564A (enExample)
CA (1) CA1220424A (enExample)
DE (2) DE3316510A1 (enExample)
DK (1) DK164148C (enExample)
ES (1) ES8505542A1 (enExample)
FR (1) FR2545354B1 (enExample)
GR (1) GR81609B (enExample)
HK (1) HK75889A (enExample)
IL (1) IL71744A (enExample)
IT (1) IT1181804B (enExample)
PT (1) PT78542B (enExample)
SG (1) SG44489G (enExample)
ZA (1) ZA843352B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016053046A (ja) * 1998-04-08 2016-04-14 アッヴィ・インコーポレイテッド 共溶媒処方物
JP2019511522A (ja) * 2016-04-13 2019-04-25 ノーティック ホールディングス インコーポレイテッド 安定なニモジピン非経口製剤
US10799486B2 (en) 2016-04-13 2020-10-13 Nortic Holdings Inc. Stable nimodipine parenteral formulation
US12414943B2 (en) 2022-05-16 2025-09-16 Grace Therapeutics U.S., Inc. Nimodipine parenteral administration

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
CA2011063C (en) * 1989-02-28 1999-07-06 Calum B. Macfarlane Nicardipine pharmaceutical composition for parenteral administration
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
EP1609477B1 (en) * 1994-12-12 2011-11-09 Omeros Corporation Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
JPH10510540A (ja) 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
CA2625862A1 (en) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Liquid pharmaceutical compositions of nimodipine
CN101431985A (zh) * 2006-04-28 2009-05-13 巴斯夫欧洲公司 在含水介质中加溶疏水活性物质的方法
EP2531548A1 (de) 2010-02-05 2012-12-12 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
US8728504B2 (en) 2010-02-05 2014-05-20 Basf Se Process for solubilizing hydrophobic active ingredients in aqueous medium
EP3238709B1 (en) 2011-04-28 2020-07-01 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
EP3755326A4 (en) 2018-02-22 2021-11-03 Nortic Holdings Inc. STABLE PARENTERAL FORMULATION OF NIMODIPINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016053046A (ja) * 1998-04-08 2016-04-14 アッヴィ・インコーポレイテッド 共溶媒処方物
JP2019511522A (ja) * 2016-04-13 2019-04-25 ノーティック ホールディングス インコーポレイテッド 安定なニモジピン非経口製剤
US10765671B2 (en) 2016-04-13 2020-09-08 Nortic Holdings Inc. Stable nimodipine parenteral formulation
US10799486B2 (en) 2016-04-13 2020-10-13 Nortic Holdings Inc. Stable nimodipine parenteral formulation
JP2021011488A (ja) * 2016-04-13 2021-02-04 ノーティック ホールディングス インコーポレイテッド 安定なニモジピン非経口製剤
US11433062B2 (en) 2016-04-13 2022-09-06 Acasti Pharma U.S., Inc. Stable nimodipine parenteral formulation
US12414943B2 (en) 2022-05-16 2025-09-16 Grace Therapeutics U.S., Inc. Nimodipine parenteral administration

Also Published As

Publication number Publication date
PT78542B (en) 1986-07-14
DK224184D0 (da) 1984-05-04
IL71744A (en) 1988-04-29
KR920000306B1 (ko) 1992-01-11
ZA843352B (en) 1984-12-24
DK224184A (da) 1984-11-07
AU2758384A (en) 1984-11-08
IL71744A0 (en) 1984-09-30
EP0126315B1 (de) 1987-01-14
ATE24835T1 (de) 1987-01-15
KR840009031A (ko) 1984-12-24
GR81609B (enExample) 1984-12-11
BE899564A (fr) 1984-11-05
CA1220424A (en) 1987-04-14
DK164148C (da) 1992-10-26
AU562293B2 (en) 1987-06-04
IT8448139A1 (it) 1985-11-04
FR2545354B1 (fr) 1986-09-26
IT8448139A0 (it) 1984-05-04
ES531995A0 (es) 1985-06-01
PT78542A (en) 1984-06-01
DK164148B (da) 1992-05-18
DE3461988D1 (en) 1987-02-19
DE3316510A1 (de) 1984-11-08
SG44489G (en) 1989-11-17
FR2545354A1 (fr) 1984-11-09
US5114956A (en) 1992-05-19
IT1181804B (it) 1987-09-30
HK75889A (en) 1989-09-29
EP0126315A1 (de) 1984-11-28
ES8505542A1 (es) 1985-06-01
JPH0422888B2 (enExample) 1992-04-20

Similar Documents

Publication Publication Date Title
JPS59206305A (ja) ニモジピンの非経口投与組成物
KR900008441B1 (ko) 옥시캄 유도체를 함유하는 제약조성물의 제조방법
JPS6169722A (ja) 医薬用組成物
KR870007118A (ko) 광학적으로 순수한 화합물 및 그의 제조 방법
DE69412662T2 (de) Angiotensin II-Antagonisten zur Behandlung von viralen Erkrankungen
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
Browne Drug therapy reviews: drug therapy of status epilepticus
DE1806926A1 (de) Lithiumsalz der Hydrochinonsulfonsaeure
JP2025534851A (ja) 複素環化合物、ならびにその調製方法および使用
US3906107A (en) Aminoalkyl sulfate esters with diuretic activity
US4062974A (en) Method for treating drepanocytosis
JPH01313433A (ja) 抗ｈｉｖ剤
EP0557876A1 (de) Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
CA2240173A1 (en) Thiamine disulfides and medicines containing the same as the active ingredient
Dax Overdosage with bromides
US3961064A (en) Pharmaceutical composition for remedy of hyperammoniemia
KR19990022036A (ko) 방사선 장해의 치료방법
JPH01156916A (ja) 肝疾患治療剤
JP2799368B2 (ja) 抗原虫剤
DE1806926C (de) Lithiumsalz der Hydrochinonsulfonsäure
JPS6272613A (ja) 播種性血管内凝固症候群予防・治療剤
US3856963A (en) Use of injectable compositions of the ({30 )-optional isomer of the alpha racemate of 2-(2-ethyl-2-phenyl-1,3-dioxolan-4-yl) piperidine to control pain
EP0547508A1 (de) Verwendung von Xanthinderivaten zur Stabilisierung der Gehirndurchblutungsautoregulation
US3517102A (en) Oxytetracycline antibiotic compositions employing n-(beta-oxyethyl) piperazine or n-n'bis - (beta - oxyethyl) piperazine and magnesium chloride
KR19990072051A (ko) 티아민디술피드류및이를유효성분으로하는의약

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees